Cell Source, Inc.
CLCS · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $75 | $22 | $223 | $93 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $50 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $162 | $173 | $187 | $221 |
| Total Curr. Assets | $287 | $195 | $410 | $314 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $172,968,000 | $0 | $0 |
| Total NC Assets | $0 | $172,968,000 | $0 | $0 |
| Other Assets | $0 | -$172,968,000 | $0 | $0 |
| Total Assets | $287 | $195 | $410 | $314 |
| Liabilities | – | – | – | – |
| Payables | $1,889 | $1,467 | $680 | $223 |
| Short-Term Debt | $10,068 | $9,254 | $7,904 | $6,469 |
| Tax Payable | $0 | $133 | $128 | $125 |
| Deferred Revenue | $0 | $0 | $0 | $3,420 |
| Other Curr. Liab. | $7,126 | $4,953 | $4,331 | -$97 |
| Total Curr. Liab. | $19,083 | $15,807 | $13,044 | $10,140 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $6,692 |
| Other Liabilities | $0 | $0 | $0 | -$6,692 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $19,083 | $15,807 | $13,044 | $10,140 |
| Equity | – | – | – | – |
| Pref Stock | $2 | $2 | $2 | $2 |
| Common Stock | $45 | $40 | $36 | $34 |
| Retained Earnings | -$46,438 | -$41,667 | -$36,346 | -$31,178 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $27,595 | $26,014 | $23,674 | $21,316 |
| Total Equity | -$18,796 | -$15,612 | -$12,634 | -$9,826 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $287 | $195 | $410 | $314 |
| Net Debt | $9,993 | $9,232 | $7,682 | $6,376 |